Following Share Rise, Hemispherx (HEB) Sets Up for Another Offering
Tweet Send to a Friend
In a Form S-3, Hemispherx BioPharma (AMEX: HEB) filed a preliminary prospectus for a $150 million mixed securities shelf. The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
